RADNOR, Pa.--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders, announced that Dr. Richard Scott, Vice President of Research at PolyMedix, presented data yesterday at the “American Society of Microbiology 7th Annual Biodefense and Emerging Diseases Research Meeting” in Baltimore relating to PolyMedix’s proprietary antimicrobial compounds.
